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DFNA23, a novel locus for autosomal dominant nonsyndromic hearing loss, was identiﬁed in a Swiss German
kindred. DNA samples were obtained from 22 family members in three generations: 10 with hearing impairment
caused by the DFNA23 locus, 8 unaffected offspring, and 4 spouses of hearing-impaired pedigree members. In this
kindred, the hearing-impaired family members have prelingual bilateral symmetrical hearing loss. All audiograms
from hearing-impaired individuals displayed sloping curves, with hearing ability ranging from normal hearing to
mild hearing loss in low frequencies, normal hearing to profound hearing loss in mid frequencies, and moderate
to profound hearing loss in high frequencies. A conductive component existed for 50% of the hearing-impaired
family members. The majority of the hearing-impaired family members did not display progression of hearing loss.
The DFNA23 locus maps to 14q21-q22. Linkage analysis was carried out under a fully penetrant autosomal
dominant mode of inheritance with no phenocopies. A maximum multipoint LOD score of 5.1 occurred at Marker
D14S290. The 3.0–LOD unit support interval is 9.4 cM and ranged from marker D14S980 to marker D14S1046.
Nonsyndromic hearing loss (NSHL) is the most genet-
ically heterogeneous trait known (Van Camp et al.
1997). Over 60 loci have been mapped and a total of
15 genes have been identiﬁed (Hereditary Hearing Loss
Homepage). This extreme genetic heterogeneity suggests
that there are many different processes that can mal-
function within the inner ear to cause hearing loss (Hel-
ler and Hudspeth 1998). Because of this extreme genetic
heterogeneity, an important strategy in mapping novel
NSHL loci has been to analyze individual kindreds that
can independently establish linkage.
Thus far, for autosomal dominant nonsyndromic
hearing loss (ADNSHL), a total of 30 loci have been
mapped, and 11 genes (COCH [MIM 601369],
COL11A2 [MIM 120290], DFNA5 [MIM 600994],
DIAPH1 [MIM 602121], GJB2 [MIM 121011], GJB3
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[MIM 603324], GJB6 [MIM 604418], KCNQ4 [MIM
603537], MYO7A [MIM 276903], POU4F3 [MIM
602460], and TECTA [MIM 602574]) have been iso-
lated. For ADNSHL only a handful of families have been
identiﬁed that segregate a particular locus with the ex-
ception of those loci for which only one family has been
identiﬁed (i.e., DFNA1 [MIM 124900]).
The Swiss-German kindred presented here (101) dis-
plays autosomal dominant bilateral early-onset hearing
loss. Kindred 101 (ﬁgure 1) was ascertained through the
Department of Otorhinolaryngology at the University
Hospital of Zurich. Informed consent was obtained from
all study participants and from the parents of underaged
study participants. A family history was obtained
through an oral interview. Audiometric and DNA sam-
ples were obtained from pedigree members in three
generations.
Blood samples were collected from 19 pedigree mem-
bers, and buccal swabs were collected from 3 family
members. Of the study subjects fromwhom a DNA sam-
ple was obtained, 10 individuals were hearing impaired
because of the DFNA23 locus, 8 individuals were un-
affected offspring, and 4 individuals were spouses of
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Figure 1 Pedigree drawing of Swiss-German kindred 101, which segregates DFNA23. The sexes of some of the family members have
been changed to protect the anonymity of the family. The genetic-map distance in centimorgans (cM) to the next marker are given in parenthesis
next to the marker name. Markers shown in bold were genotyped for the genome scan. Filled symbols represent individuals with hearing
impairment caused by DFNA23. Gray symbols represent individuals whose hearing status is unknown. Unﬁlled symbols represent unaffected
individuals. Haplotypes for the most–closely linked STRPs are shown below each symbol. Question marks indicate an unknown allele. The
haplotype segregating with the disease allele appears in rectangles. The 3 allele from marker D14S274 is underlined for those individuals where
it is not possible to elucidate whether marker D14S274 is part of the disease haplotype.
hearing-impaired pedigree members. Auditory thresh-
olds were determined by standard pure-tone audiometry
with air conduction at 125–8000 Hz and bone conduc-
tion at 250–4000 Hz. In addition, where possible, pre-
vious audiological tests were collected. The history and
records of the hearing-impaired family member sug-
gested a prelingual onset at birth or in the ﬁrst years of
life. The majority of the affected family members did
not display progression of hearing loss during a followup
period which varied between 6 and 32 years. The hearing
loss showed progression in only three cases. Audiometry
displayed a bilateral and symmetrical hearing loss. In
ﬁve cases there existed a conductive component (which
produced an air-bone gap between 10 dB and 40 dB).
All audiograms showed sloping curves, with normal
hearing to mild hearing loss in low frequencies, normal
hearing to profound hearing loss in middle frequencies,
and moderate to profound hearing loss in high
frequencies.
DNA was extracted from 10 ml of blood by use of
standard techniques (Miller et al. 1988). A genome scan
was carried out on 19 DNA samples at the National
Heart, Lung, and Blood Institute (NHLBI) mammalian
genotyping service, using Marshﬁeld screening set 9
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Table 1
Two-Point LOD Score Results between the DFNA23 Locus and
Chromosome 14 Markers
MARKER
LOD SCORE AT v =
.0 .01 .05 .10 .20 .30 .40
D14S587  2.14 .25 .37 .71 .63 .38
D14S276  1.46 .16 .28 .49 .41 .21
GATA84B02  1.09 .20 .63 .81 .68 .39
D14S282  2.13 .23 .41 .77 .70 .41
D14S285  1.55 .30 .88 1.09 .87 .45
D14S980  .95 .86 1.39 1.50 1.16 .61
D14S274 .76 .76 .71 .64 .47 .27 .08
D14S592 3.91 3.85 3.58 3.23 2.46 1.61 .73
D14S997 4.21 4.14 3.86 3.48 2.67 1.78 .85
D14S290 5.12 5.03 4.69 4.25 3.28 2.19 1.01
D14S63 2.41 2.36 2.19 1.95 1.44 .87 .3
D14S1046  5.49 2.21 .94 .05 .35 .31
D14S1069  .75 1.86 2.08 1.87 1.31 .59
D14S540  1.37 1.9 1.96 1.7 1.2 .57
D14S1011 1.53 1.53 1.48 1.37 1.07 .69 .27
D14S588  .67 1.19 1.25 1.07 .75 .4
(Yuan et al. 1997). A total of 386 ﬂuorescently labeled
simple tandem repeat (STRP) markers were genotyped,
with an average heterozygosity of 0.76. These markers
are spaced ∼10 cM apart and are located on the 22
autosomes and the X and Y chromosomes.
Linkage analysis was carried out under a fully pene-
trant autosomal dominant mode of inheritance with no
phenocopies. A disease frequency of .001 was used in
the analysis. The marker-allele frequencies were esti-
mated from the data by means of both observed and
reconstructed genotypes of founders within this pedigree
and other Swiss-German pedigrees. It should be noted
that, since almost all family members are genotyped,
pedigree 101 is very robust to changes in marker allele
frequencies, varying marker allele frequencies having lit-
tle or no effect on the LOD score results. Two-point
linkage analysis was carried out on all autosomal mark-
ers from the genome scan by means of the MLINK pro-
gram of the FASTLINK computer package (Cottingham
et al. 1993). A maximum two-point LOD score of 3.9
with marker D14S592 was obtained. No other marker
gave a LOD score 3. Flanking markers to D14S592,
D14S587, and D14S588 produced maximum LOD
scores of 0.71 (at recombination fraction [v] = .22) and
1.3 (at ), respectively. Multipoint linkage analysis,v = .09
performed with the LINKMAP program of the FAS-
TLINK computer package, ruled out the possibility that
the DFNA23 locus lies between D14S587 and D14S306
or between D14S588 and D14S53 (data not shown).
For ﬁne mapping, 13 additional markers were selected
from the Marshﬁeld map (Broman et al. 1998); 6 of
these markers—D14S276, GATA84B02, D14S282,
D14S285, D14S980, and D14S274—lie between
D14S587 and D14S592, and an additional 7 mark-
ers—D14S997, D14S290, D14S63, D14S1046,
D14S1069, D14S540, and D14S1011—lie between
D14S592 and D14S588 (ﬁg. 1). No other markers were
available from this region that would allow for ﬁner
mapping of the DFNA23 locus. For these markers, 22
DNA samples were genotyped: the 19 DNA samples
included in the genome scan plus three additional DNA
samples—III.1, III.4, and IV.1—for which only a limited
amount of DNA was available, since a buccal swab had
been collected. The data were reanalyzed using two-
point and multipoint linkage analysis. The results of the
two-point linkage analysis are displayed in table 1. A
maximum two-point LOD score of 5.1 was obtained at
for marker D14S290. A graph of the results of thev = 0
multipoint analysis is displayed in ﬁgure 2. Since marker
D14S290 is fully informative an identical maximum
multipoint lod score of 5.1 was obtained at this marker.
Marker D14S290 maps to 68.6 cM from the telomere.
The 3.0-LOD unit support interval for DFNA23 ranges
from 60.4 cM to 69.8 cM (9.4 cM).
SIMWALK2 (Weeks et al. 1995; Sobel and Lange
1996) was used to generate the haplotypes with the high-
est likelihood (ﬁg. 1). The interval that DFNA23 maps
to is ﬂanked by recombination events at marker
D14S980 (60.4 cM) and D14S1046 (69.8 cM). The in-
terval between these two markers is 9.4 cM. If the hap-
lotypes (ﬁg. 1) are examined, marker D14S274 cannot
be placed within the disease haplotype unequivocally.
For those individuals for whom it is not possible to elu-
cidate whether D14S274 is part of the disease haplotype,
the 3 allele is underlined. On the basis of haplotype
reconstruction of the parents of II.1, II.2, II.3, II.5, and
II.6 (data not shown), the parent carrying the disease
allele was homozygous at marker D14S274. Therefore,
for individual II.6, it is not possible to tell whether
a recombination event occurred between markers
D14S980 and D14S274 or between D14S274 and
D14S592. Furthermore, for individuals III.2 and IV.4,
the affected parents are also homozygous at marker
D14S274, so it is impossible to elucidate whether a
recombination event occurred between markers
D14S980 and D14S274 or between D14S274 and
D14S592. If marker D14S274 is not part of the disease
haplotype, then the haplotype for DFNA23 is 6.6 cM.
However, since it is impossible to rule out that marker
D14S274 is part of the disease haplotype, a fairer
estimate of the haplotype length is 9.4 cM.
In considering candidate genes for DFNA23, the most
interest lies in those genes which map to 14q21-q22 and
are expressed in the cochlea. Although genes expressed
in other portions of the auditory pathway could also be
involved in causing NSHL, genes expressed in the coch-
lea are good candidates for DFNA23, since all known
mutations leading to deafness in humans occur in genes
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Figure 2 Results from the multipoint linkage analysis. A maximum multipoint LOD score of 5.1 occurred at marker D14S290 at 68.6
cM. The interval that DFNA23 maps to is ﬂanked by recombination events at marker D14S980 and D14S1046.
that are expressed in the specialized cell types of the
cochlea.
In the region 14q21-q22, there are a number of genes
that are expressed in the human fetal cochlea: human
protein kinase C-h gene (Quan and Fisher 1999); reti-
culon (RTN1 [MIM 600865]); kinectin (KTN1 [MIM
600381]); heat shock 10-KD protein (HSPE1 [MIM
600141]), hypoxia-inducible factor 1, alpha subunit
(HIF1A [MIM 603348]); and nidogen 2 (NID2 [Koh-
feldt et al. 1998]) (Human Cochlear cDNA Library and
EST Database). There are also genes that map to this
region that are expressed in the cochlea of nonhuman
vertebrates: alpha-actinin (alpha 1) (ACTN1 [MIM
102575]), bone morphogenetic protein 4 (BMP4 [MIM
112262]), and homolog of Drosophila orthodenticle 2
(OTX2 [MIM 600037]) (see Bussoli and Steel, Table of
Gene Expression in the Developing Ear). Among these
many genes, the strongest candidate genes for DFNA23
are ACTN1, NID2, and KTN1.
ACTN1 was found to be expressed in adult rat cu-
ticular plate, the organ of Corti, the stereocilia of the
outer and inner hair cells, pillar cells, and supporting
cells (Zine and Romand 1993). Not only does the ex-
pression information on ACTN1 make it an attractive
candidate for DNA23, but also the fact that another
widely expressed actin-associated protein, the human
homologue of Drosophila melanogaster diaphanous
(DIAPH1 [MIM 602121]), is responsible for NSHL due
to DFNA1 (MIM 124900) further strengthens the evi-
dence that ACTN1 is a candidate for DFNA23.
NID2 is also a good candidate for DFNA23, since it
has been shown that NID2 can bind the networks of
collagen IV and laminin in situ and thereby stabilize the
basement-membrane architecture (Kohfeldt et al. 1998).
Mutations within COL4A3 (MIM 120070), COL4A4
(MIM 120131), COL4A5 (MIM 303630), and
COL4A6 (MIM 303631) are responsible for Alport syn-
drome (MIM 203780), for which one of the features is
progressive sensorineural hearing loss. NID2 has also
been shown to bind to collagen I (Kohfeldt et al. 1998).
Mutations in COL1A1 (MIM 120150) have been shown
to cause osteogenesis imperfecta congenita (OIC [MIM
166210]) with sensorineural and/or conductive hearing
loss.
KTN1 is another strong candidate for DFNA23. This
gene encodes a human protein with extensive coiled-coil
structure, which is similar to the coiled-coil tail of the
Myosin-II family (Print et al. 1994). Mutations in two
myosin genes have been found to be responsible for
NSHL, myosin VIIA gene (MYO7A [MIM 276903]) is
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responsible for DFNB2 (MIM 600060) and DFNA11
(MIM 601317), and the Myosin 15 gene (MYO15
[MIM 602666]) is responsible for DFNB3 (MIM
600316).
Linkage of the DFNA23 locus to 14q21-q22 is an
essential ﬁrst step in gene identiﬁcation that will provide
insight into the pathophysiology of this disorder. Al-
though the gene for DFNA23, like its autosomal dom-
inant counterparts, will not play a major role in the
etiology of hearing loss, identiﬁcation of this gene will
aid in understanding the mechanism of hearing and hear-
ing loss.
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